ES2087217T3 - Tratamiento de trastornos del sueño mediante el uso de ciertos antidepresivos, como por ejemplo la nefazodona. - Google Patents

Tratamiento de trastornos del sueño mediante el uso de ciertos antidepresivos, como por ejemplo la nefazodona.

Info

Publication number
ES2087217T3
ES2087217T3 ES91120587T ES91120587T ES2087217T3 ES 2087217 T3 ES2087217 T3 ES 2087217T3 ES 91120587 T ES91120587 T ES 91120587T ES 91120587 T ES91120587 T ES 91120587T ES 2087217 T3 ES2087217 T3 ES 2087217T3
Authority
ES
Spain
Prior art keywords
nefazodone
treatment
sleep disorders
certain antidepressants
antidepressants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91120587T
Other languages
English (en)
Inventor
Richard Gammans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Squibb Co
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of ES2087217T3 publication Critical patent/ES2087217T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Anesthesiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

SE HA DESCUBIERTO QUE CIERTOS ANTIDEPRESIVOS, COMO EL NEFAZODONE, SIRVEN PARA ALIVIAR LOS DESORDENES DEL SUEÑO ASOCIADOS CON UN REM DEL SUEÑO MENOR QUE NORMAL.
ES91120587T 1990-12-03 1991-11-29 Tratamiento de trastornos del sueño mediante el uso de ciertos antidepresivos, como por ejemplo la nefazodona. Expired - Lifetime ES2087217T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/620,696 US5116852A (en) 1990-12-03 1990-12-03 Treatment of sleep disorders

Publications (1)

Publication Number Publication Date
ES2087217T3 true ES2087217T3 (es) 1996-07-16

Family

ID=24487000

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91120587T Expired - Lifetime ES2087217T3 (es) 1990-12-03 1991-11-29 Tratamiento de trastornos del sueño mediante el uso de ciertos antidepresivos, como por ejemplo la nefazodona.

Country Status (11)

Country Link
US (1) US5116852A (es)
EP (1) EP0493687B1 (es)
JP (1) JP3062974B2 (es)
AT (1) ATE136777T1 (es)
CA (1) CA2056201A1 (es)
DE (1) DE69118859T2 (es)
DK (1) DK0493687T3 (es)
ES (1) ES2087217T3 (es)
GR (1) GR3019692T3 (es)
IL (1) IL100183A (es)
MX (1) MX9101994A (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
US5502047A (en) * 1993-03-22 1996-03-26 Kavey; Neil B. Treatment for insomnia
AU7025396A (en) 1995-10-17 1997-05-01 Bristol-Myers Squibb Company Nefazodone: treatment of panic attack
WO1998004261A1 (en) * 1996-07-31 1998-02-05 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US6008222A (en) * 1996-12-04 1999-12-28 Bristol-Myers Squibb Company Method for oral administration of buspirone and nefazodone
DE69930952T2 (de) * 1998-11-02 2006-08-31 Alza Corp., Mountain View Verfahren und Vorrichtung zur kontrollierten Abgabe pharmazeutischer Mittel sowie Dosierungsform hierfür
AU4215400A (en) 1999-04-09 2000-11-14 Sepracor, Inc. S-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
WO2000061128A2 (en) 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
US20060009465A1 (en) * 2002-01-18 2006-01-12 Dale Edgar Treatment of sleep disorders using sleep target modulators
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
EP1691811B1 (en) * 2003-12-11 2014-07-23 Sunovion Pharmaceuticals Inc. Combination of a sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
US20100179214A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin trans isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136845A2 (en) 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. Low-dose doxepin for treatment of sleep disorders in elderly patients
US20100179215A1 (en) 2006-05-19 2010-07-15 Somaxon Pharmaceuticals, Inc. Doxepin isomers and isomeric mixtures and methods of using the same to treat sleep disorders
WO2007136741A2 (en) * 2006-05-19 2007-11-29 Somaxon Pharmaceuticals, Inc. N-desmethyl-doxepin and methods of using the same to treat sleep disorders
US8513299B2 (en) 2006-05-19 2013-08-20 Pernix Sleep, Inc. Methods of using low-dose doxepin for the improvement of sleep
CA2693992C (en) * 2006-07-20 2017-01-31 Somaxon Pharmaceuticals, Inc. Methods of improving the pharmacokinetics of doxepin
WO2008085567A1 (en) * 2006-10-04 2008-07-17 Somaxon Pharmaceuticals, Inc. Methods of using low-dose doxepin for the improvement of sleep
US20100105614A1 (en) 2006-10-25 2010-04-29 Somaxon Pharmaceuticals, Inc. Ultra low dose doxepin and methods of using the same to treat sleep disorders
US20110077200A1 (en) 2006-12-06 2011-03-31 Somaxon Pharmaceuticals, Inc. Combination therapy using low-dose doxepin for the improvement of sleep
US20090074862A1 (en) 2007-04-13 2009-03-19 Luigi Schioppi Low-dose doxepin formulations and methods of making and using the same
US9339500B2 (en) * 2008-03-04 2016-05-17 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
CN111874148B (zh) 2020-08-21 2024-07-09 北京小米移动软件有限公司 折叠结构、折叠设备和折叠车

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4338317A (en) * 1981-03-16 1982-07-06 Mead Johnson & Company Phenoxyethyl-1,2,4,-triazol-3-one antidepressants

Also Published As

Publication number Publication date
GR3019692T3 (en) 1996-07-31
EP0493687A2 (en) 1992-07-08
MX9101994A (es) 1992-06-01
EP0493687A3 (en) 1992-07-22
CA2056201A1 (en) 1992-06-04
JP3062974B2 (ja) 2000-07-12
IL100183A0 (en) 1992-08-18
JPH04300873A (ja) 1992-10-23
IL100183A (en) 1996-12-05
ATE136777T1 (de) 1996-05-15
DE69118859D1 (de) 1996-05-23
DE69118859T2 (de) 1996-09-05
DK0493687T3 (da) 1996-05-13
US5116852A (en) 1992-05-26
EP0493687B1 (en) 1996-04-17

Similar Documents

Publication Publication Date Title
ES2087217T3 (es) Tratamiento de trastornos del sueño mediante el uso de ciertos antidepresivos, como por ejemplo la nefazodona.
MX9305269A (es) Utilizacion del receptor de il-4 para la terapia,la profilaxis y el diagnostico de enfermedades alergicas, viricas, parasitarias y bacterianas asi como de infecciones por hongos.
FI925549A0 (fi) Nya azaheterocyklylmetyl-kromaner
ES2170141T3 (es) 4-aminoderivados del acido micofenolico con actividad inmunosupresora.
PA8447801A1 (es) Derivados del acido hexanoico
ES2184106T3 (es) Utilizacion del derivado de k-252a en el tratamiento de trastornos del sistema nervioso periferico o central, y de la hiperproduccion de citoquinas.
ATE206708T1 (de) Benzimidazolonderivate mit zentraler dopaminerger aktivität
AR028705A1 (es) Bis-arilsulfonas
SE9701161D0 (sv) New use I
ES2075378T3 (es) Procedimiento para la preparacion del factor viii humano y de analogos del factor viii.
DE69130497D1 (de) Neue Verwendung von 1-Alpha-hydroxylierten-19-nor-vitamin-D-Verbindungen zur Behandlung von Psoriasis
ATE133680T1 (de) Oligosaccharidderivate und deren verwendung in heilmitteln
IT8005106A0 (it) Composti per il trattamento del glaucoma.
ES2066096T3 (es) 4-bencil-5-fenil-2,4-dihidro-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
DK578887A (da) Antihypertensiva
ES2076141T3 (es) 5-aril-3h-1,2,4-triazol-3-onas y su uso como anticonvulsivos.
IT1225483B (it) Protesi ortopedica, particolarmente per la testa del femore.
ES2144857T3 (es) Utilizacion de derivados benzonaftalenicos para la fabricacion de medicamentos destinados para el tratamiento de las enfermedades del sistema nervioso.
ES2171838T3 (es) Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar.
NO970607D0 (no) Anordning av selegilin i behandling av epileptiske tilstander
MX9204896A (es) Tiazepinas substituidas como agentes del sistema nervioso central.
MX9207156A (es) Empleo de derivados de xantina para la estabilizacion de la auto-regulacion del riego sanguineo del cerebro.
IT209533Z2 (it) Letto, munito di comodini, spostabili lungo l'asse longitudinale del letto.
SU510245A1 (ru) Способ лечени фазно-протекающих психозов
ES2153854T3 (es) Uso de compuestos de triazina para el tratamiento de trastornos de la memoria y del aprendizaje.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 0493687

Country of ref document: ES